HOTH
Rocket One Inc
Price Chart
Latest Quote
$1.36
+0.00 (+0.00%)
Current Price
| Previous Close | $1.36 |
| Open | $0.87 |
| Day High | $1.36 |
| Day Low | $1.36 |
| Volume | 135,373,627 |
Stock Information
| Shares Outstanding | 19.13M |
| Total Debt | $6K |
| Cash Equivalents | $6.25M |
| Net Income | $-12.47M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $26.01M |
| EPS (TTM) | $-0.80 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.05M |
| Income | $-12.47M |
| Book/sh | $0.40 |
| Cash/sh | $0.33 |
| Employees | 2 |
Financial Ratios
| Quick Ratio | 4.30 |
| Current Ratio | 4.72 |
| Debt/Eq | 0.09 |
Returns & Margins
| ROA | -100.89% |
| ROE | -191.40% |
Ownership
| Insider Ownership | 2.89% |
| Institutional Ownership | 4.11% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.92 |
| P/B | 3.43 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.34 |
| SMA50 | $0.95 |
| SMA200 | $1.13 |
| RSI | 43.26 |
| ATR | 0.3582 |
| Shares Float | 15.79M |
| Short Float | 4.29% |
| Short Ratio | 0.13 |
| Volatility | 0.58 |
| Rel Volume | 0.09 |
Performance History
| Week | -27.03% |
| Month | +80.00% |
| Quarter | +16.96% |
| 6 Months | +2.86% |
| YTD | +0.93% |
| Year | -16.92% |
| 3 Years | -63.88% |
| 5 Years | -97.28% |
| 10 Years | -99.49% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.08 | 1,887,061 |
| 2026-06-17 | $1.10 | 1,401,910 |
| 2026-06-16 | $1.17 | 4,789,855 |
| 2026-06-15 | $1.03 | 6,721,241 |
| 2026-06-12 | $1.12 | 22,608,918 |
| 2026-06-11 | $1.48 | 21,742,699 |
| 2026-06-10 | $1.33 | 4,208,407 |
| 2026-06-09 | $1.28 | 5,627,851 |
| 2026-06-08 | $1.39 | 3,703,876 |
| 2026-06-05 | $1.51 | 8,981,014 |
| 2026-06-04 | $1.97 | 12,056,387 |
| 2026-06-03 | $2.14 | 15,157,498 |
| 2026-06-02 | $2.22 | 39,144,966 |
| 2026-06-01 | $1.34 | 7,422,219 |
| 2026-05-29 | $1.46 | 23,467,326 |
| 2026-05-28 | $1.70 | 93,911,605 |
| 2026-05-27 | $1.36 | 165,804,715 |
| 2026-05-26 | $0.71 | 483,070 |
About Rocket One Inc
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs in the United States. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; and HT-004 for treatment of asthma and allergies using inhalational administration. The company is developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; ZylÃļ Therapeutics, Inc.; and Voltron Therapeutics, Inc. The company was incorporated in 2017 and is based in Hoboken, New Jersey.
đ° Latest News
RKTO Stock Extends Rally After Landing Its First AI Catalyst â Retail Bulls Are Chasing An AI-Space Dream
Stocktwits âĸ 2026-05-28T13:33:48Z
From biotech to orbit: Rocket One's AI and space rebrand sends shares flying
Reuters âĸ 2026-05-28T11:34:21Z
MNTS, ASTC, RKTO Soar As NASA Ramps Up Moon Missions â But Isaacman Warns Orbital Economy Is âGrossly Overstatedâ
Stocktwits âĸ 2026-05-28T01:39:48Z
HOTHâs Pivot From Biotech To Space Tech Sparks Massive Rally In Stock â Retail Underlines Importance Of Securing Fresh Deals
Stocktwits âĸ 2026-05-27T17:48:54Z
Rocket One Rebrand Marks Strategic Shift Toward Space AI Chip and Orbital Computing Markets (RKTO)
InvestorsHub âĸ 2026-05-27T15:49:05Z
Hoth Therapeutics shares slide after shift toward AI semiconductor strategy (HOTH)
InvestorsHub âĸ 2026-05-19T13:29:23Z
EXCLUSIVE: Hoth Therapeutics To Rebrand To Pursue AI Chip Technologies
Benzinga âĸ 2026-05-19T11:46:09Z
Sector Update: Health Care Stocks Advance Late Afternoon
MT Newswires âĸ 2026-01-02T20:53:59Z2 Stocks to Buy Under $10 That Wall Street Loves
Barchart âĸ 2025-10-29T11:30:02Z
NVDA: Nvidia Stock Breaks New Record After Cantor Hikes Price Target to $300
GuruFocus.com âĸ 2025-10-09T19:21:23Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $12,361,349 | $8,215,432 | $7,952,974 | $11,065,554 |
| Rent Expense Supplemental | $54,000 | $53,000 | - | $66,834 |
| Other Income Expense | $-107,953 | $27,132 | $-153,148 | $-312,769 |
| Operating Expense | $12,361,349 | $8,215,432 | $7,952,974 | $11,065,554 |
| General And Administrative Expense | $6,414,989 | $4,966,336 | $4,212,189 | $6,134,390 |
| Net Non Operating Interest Income Expense | - | - | $781 | $6,370 |
| Other Non Operating Income Expenses | - | - | - | $451,140 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-12,469,302 | $-8,188,300 | $-8,106,122 | $-11,371,953 |
| Normalized Income | $-12,361,349 | $-8,216,013 | $-7,948,574 | $-10,985,044 |
| Net Income From Continuing And Discontinued Operation | $-12,469,302 | $-8,188,300 | $-8,106,122 | $-11,371,953 |
| Total Operating Income As Reported | $-12,361,349 | $-8,215,432 | $-7,952,974 | $-11,065,554 |
| Net Income Common Stockholders | $-12,469,302 | $-8,188,300 | $-8,106,122 | $-11,370,963 |
| Net Income | $-12,469,302 | $-8,188,300 | $-8,106,122 | $-11,371,953 |
| Net Income Including Noncontrolling Interests | $-12,469,302 | $-8,188,300 | $-8,106,122 | $-11,371,953 |
| Net Income Continuous Operations | $-12,469,302 | $-8,188,300 | $-8,106,122 | $-11,371,953 |
| Pretax Income | $-12,469,302 | $-8,188,300 | $-8,106,122 | $-11,371,953 |
| Earnings From Equity Interest | $0 | $-581 | $4,400 | $-377,000 |
| Operating Income | $-12,361,349 | $-8,215,432 | $-7,952,974 | $-11,065,554 |
| Net Interest Income | - | - | $781 | $6,370 |
| Interest Income | - | - | $781 | $6,370 |
| Interest Income Non Operating | - | - | $781 | $6,370 |
| Per Share | ||||
| Diluted EPS | - | $-1.28 | $-2.38 | $-9.50 |
| Basic EPS | - | $-1.28 | $-2.38 | $-9.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-12,253,396 | $-8,243,145 | $-7,795,426 | $-10,678,645 |
| Total Unusual Items | $-107,953 | $27,713 | $-157,548 | $-386,909 |
| Total Unusual Items Excluding Goodwill | $-107,953 | $27,713 | $-157,548 | $-386,909 |
| EBITDA (Bullshit earnings) | $-12,361,349 | $-8,215,432 | $-7,952,974 | $-11,065,554 |
| EBIT | $-12,361,349 | $-8,215,432 | $-7,952,974 | $-11,065,554 |
| Diluted NI Availto Com Stockholders | $-12,469,302 | $-8,188,300 | $-8,106,122 | $-11,370,963 |
| Gain On Sale Of Security | $-107,953 | $27,713 | $-157,548 | $-386,909 |
| Research And Development | $5,946,360 | $3,249,096 | $3,740,785 | $4,931,164 |
| Selling General And Administration | $6,414,989 | $4,966,336 | $4,212,189 | $6,134,390 |
| Other Gand A | $3,519,989 | $2,662,336 | $4,212,189 | $6,134,390 |
| Rent And Landing Fees | $54,000 | $53,000 | - | $66,834 |
| Salaries And Wages | $2,841,000 | $2,251,000 | - | $2,588,595 |
| Diluted Average Shares | - | $6,375,161 | $3,409,190 | $1,197,521 |
| Basic Average Shares | - | $6,375,161 | $3,409,190 | $1,197,521 |
| Preferred Stock Dividends | - | - | - | $-990 |
| Reconciled Depreciation | - | - | - | - |
Fetched: 2026-05-24
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $6,150,769 | $6,878,859 | $9,538,060 | $5,121,650 |
| Total Assets | $7,603,444 | $7,712,765 | $10,243,043 | $6,759,381 |
| Total Non Current Assets | $740,891 | $67,894 | $92,565 | $33,000 |
| Other Non Current Assets | $699,420 | - | - | - |
| Current Assets | $6,862,553 | $7,644,871 | $10,150,478 | $6,726,381 |
| Current Deferred Assets | $57,171 | $0 | - | - |
| Prepaid Assets | $366,548 | $559,179 | $811,357 | $88,450 |
| Cash Cash Equivalents And Short Term Investments | $6,438,834 | $7,038,923 | $9,292,352 | $6,637,931 |
| Cash And Cash Equivalents | $6,247,467 | $7,038,923 | $9,292,352 | $6,428,611 |
| Cash Financial | $6,247,467 | $7,038,923 | $9,292,352 | $6,428,611 |
| Receivables | - | $46,769 | $46,769 | $0 |
| Other Receivables | - | $46,769 | $46,769 | - |
| Notes Receivable | - | - | - | $0 |
| Non Current Note Receivables | - | - | - | - |
| Debt | ||||
| Total Debt | $5,678 | $31,075 | $55,165 | $0 |
| Long Term Debt And Capital Lease Obligation | $0 | $2,709 | $26,326 | $0 |
| Current Debt And Capital Lease Obligation | $5,678 | $28,366 | $28,839 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,452,675 | $833,906 | $704,983 | $1,637,731 |
| Total Non Current Liabilities Net Minority Interest | $0 | $2,709 | $26,326 | $250,000 |
| Current Liabilities | $1,452,675 | $831,197 | $678,657 | $1,387,731 |
| Payables And Accrued Expenses | $1,446,997 | $802,831 | $649,818 | $1,387,731 |
| Payables | $823,674 | $412,071 | $35,592 | $694,989 |
| Accounts Payable | $823,674 | $412,071 | $35,592 | $694,989 |
| Equity | ||||
| Common Stock Equity | $6,150,769 | $6,878,859 | $9,538,060 | $5,121,650 |
| Total Equity Gross Minority Interest | $6,150,769 | $6,878,859 | $9,538,060 | $5,121,650 |
| Stockholders Equity | $6,150,769 | $6,878,859 | $9,538,060 | $5,121,650 |
| Gains Losses Not Affecting Retained Earnings | $10,831 | $9,063 | $27,260 | $22,006 |
| Other Equity Adjustments | $10,831 | $9,063 | $27,260 | $22,006 |
| Retained Earnings | $-72,879,343 | $-60,410,041 | $-52,221,741 | $-45,099,116 |
| Long Term Equity Investment | $36,819 | $36,819 | $37,400 | $33,000 |
| Other | ||||
| Ordinary Shares Number | $15,514,312 | $8,042,747 | $4,348,129 | $1,302,113 |
| Share Issued | $15,514,312 | $8,042,747 | $4,348,129 | $1,302,113 |
| Tangible Book Value | $6,150,769 | $6,878,859 | $9,538,060 | $5,121,650 |
| Invested Capital | $6,150,769 | $6,878,859 | $9,538,060 | $5,121,650 |
| Working Capital | $5,409,878 | $6,813,674 | $9,471,821 | $5,338,650 |
| Capital Lease Obligations | $5,678 | $31,075 | $55,165 | $0 |
| Total Capitalization | $6,150,769 | $6,878,859 | $9,538,060 | $5,121,650 |
| Additional Paid In Capital | $79,017,730 | $67,279,033 | $61,732,106 | $50,198,630 |
| Capital Stock | $1,551 | $804 | $435 | $130 |
| Common Stock | $1,551 | $804 | $435 | $130 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $2,709 | $26,326 | $0 |
| Current Capital Lease Obligation | $5,678 | $28,366 | $28,839 | $0 |
| Current Accrued Expenses | $623,323 | $390,760 | $614,226 | $692,742 |
| Investments And Advances | $36,819 | $36,819 | $37,400 | $33,000 |
| Investmentsin Joint Venturesat Cost | $36,819 | $36,819 | $37,400 | $33,000 |
| Net PPE | $4,652 | $31,075 | $55,165 | $0 |
| Accumulated Depreciation | $-26,423 | $0 | $-4,533 | - |
| Gross PPE | $31,075 | $31,075 | $59,698 | $0 |
| Buildings And Improvements | $31,075 | $31,075 | $59,698 | - |
| Properties | $0 | $0 | $0 | - |
| Other Short Term Investments | $191,367 | $0 | $0 | $209,320 |
| Non Current Accrued Expenses | - | - | $0 | $250,000 |
| Other Properties | - | - | $55,165 | - |
Fetched: 2026-05-24
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-9,803,918 | $-6,978,251 | $-8,447,094 | $-9,371,854 |
| Operating Activities | ||||
| Operating Cash Flow | $-9,803,918 | $-6,978,251 | $-8,447,094 | $-9,297,854 |
| Cash Flow From Continuing Operating Activities | $-9,803,918 | $-6,978,251 | $-8,447,094 | $-9,297,854 |
| Operating Gains Losses | - | $581 | $204,920 | $944,692 |
| Investing Activities | ||||
| Investing Cash Flow | $-300,000 | $0 | $0 | $1,161,695 |
| Cash Flow From Continuing Investing Activities | $-300,000 | $0 | $0 | $1,161,695 |
| Capital Expenditure | - | - | - | $-74,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $4,118,865 | $1,060,719 | $11,314,998 | $5,986,103 |
| Financing Cash Flow | $9,310,694 | $4,743,019 | $11,317,353 | $6,036,093 |
| Cash Flow From Continuing Financing Activities | $9,310,694 | $4,743,019 | $11,317,353 | $6,036,093 |
| Net Other Financing Charges | $-433,171 | - | - | $50,000 |
| Net Common Stock Issuance | $4,118,865 | $1,060,719 | $11,314,998 | $5,985,103 |
| Common Stock Issuance | $4,118,865 | $1,060,719 | $11,314,998 | $5,985,103 |
| Repurchase Of Capital Stock | - | - | $0 | $-10 |
| Net Preferred Stock Issuance | - | - | $0 | $990 |
| Preferred Stock Issuance | - | - | $0 | $1,000 |
| Other | ||||
| End Cash Position | $6,247,467 | $7,038,923 | $9,292,352 | $6,428,611 |
| Beginning Cash Position | $7,038,923 | $9,292,352 | $6,428,611 | $8,538,270 |
| Effect Of Exchange Rate Changes | $1,768 | $-18,197 | $-6,518 | $-9,593 |
| Changes In Cash | $-793,224 | $-2,235,232 | $2,870,259 | $-2,100,066 |
| Proceeds From Stock Option Exercised | $5,625,000 | $3,682,300 | $2,355 | $0 |
| Net Investment Purchase And Sale | $-300,000 | $0 | $0 | $1,235,695 |
| Purchase Of Investment | $-300,000 | $0 | - | $0 |
| Change In Working Capital | $184,146 | $405,191 | $-487,320 | $594,479 |
| Change In Payables And Accrued Expense | $644,166 | $153,013 | $-700,752 | $590,632 |
| Change In Prepaid Assets | $-460,020 | $252,178 | $213,432 | $3,847 |
| Other Non Cash Items | $1,293,309 | - | $-275,000 | $34,000 |
| Stock Based Compensation | $1,187,929 | $804,277 | $216,428 | $620,798 |
| Gain Loss On Sale Of Business | $0 | $581 | $-4,400 | $377,000 |
| Net Income From Continuing Operations | $-12,469,302 | $-8,188,300 | $-8,106,122 | $-11,371,953 |
| Preferred Stock Payments | - | - | $0 | $-10 |
| Sale Of Investment | - | - | $0 | $1,235,695 |
| Net Intangibles Purchase And Sale | - | - | $0 | $-74,000 |
| Purchase Of Intangibles | - | - | $0 | $-74,000 |
| Unrealized Gain Loss On Investment Securities | - | - | $209,320 | $-119,870 |
| Earnings Losses From Equity Investments | - | - | $-4,400 | $377,000 |
| Gain Loss On Investment Securities | - | - | $209,320 | $567,692 |
| Net Foreign Currency Exchange Gain Loss | - | - | - | $0 |
| Net Business Purchase And Sale | - | - | - | - |
| Purchase Of Business | - | - | - | - |
| Change In Payable | - | - | - | - |
| Change In Account Payable | - | - | - | - |
| Depreciation Amortization Depletion | - | - | - | - |
| Depreciation And Amortization | - | - | - | - |
| Depreciation | - | - | - | - |
Fetched: 2026-05-24